Amgen Inc. et al v. MSN Laboratories Private Limited et al
| Amgen Inc. and KAI Pharmaceuticals, Inc. |
| MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. and MSN Life Sciences Private Limited |
| 1:2023cv00031 |
| January 12, 2023 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 10, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 12
SO ORDERED re (11 in 1:23-cv-00031-MN, 154 in 1:21-cv-00662-MN) Stipulation of Voluntary Dismissal without Prejudice and Proposed Consolidation Order. Party MSN Life Sciences Private Limited terminated. Attorney Kenneth Laurence Dorsney terminated as to this Defendant. Signed by Judge Maryellen Noreika on 2/10/2023. (dlw)
|
| Filing 11 STIPULATION of Voluntary Dismissal without Prejudice and Proposed Consolidation Order by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) |
| Case associated with lead case: Create association to 1:21-cv-00662-MN. (dlw) |
| Filing 10 STIPULATION TO EXTEND TIME for MSN Defendants to answer, move or otherwise respond to the Complaint to February 10, 2023 - filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) |
|
SO ORDERED re #10 STIPULATION TO EXTEND TIME for MSN Defendants to answer, move or otherwise respond to the Complaint to February 10, 2023 (Set/Reset Answer Deadlines: MSN Laboratories Private Limited answer due 2/10/2023; MSN Life Sciences Private Limited answer due 2/10/2023; MSN Pharmaceuticals Inc. answer due 2/10/2023). ORDERED by Judge Maryellen Noreika on 2/3/2023. (dlw)
|
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 9 SUMMONS Returned Executed by Amgen Inc., KAI Pharmaceuticals, Inc..MSN Pharmaceuticals Inc. served on 1/13/2023, answer due 2/3/2023. (Clark, Cameron) |
| Filing 8 SUMMONS Returned Executed by Amgen Inc., KAI Pharmaceuticals, Inc..MSN Life Sciences Private Limited served on 1/13/2023, answer due 2/3/2023. (Clark, Cameron) |
| Filing 7 SUMMONS Returned Executed by Amgen Inc., KAI Pharmaceuticals, Inc..MSN Laboratories Private Limited served on 1/13/2023, answer due 2/3/2023. (Clark, Cameron) |
| Filing 6 Summons Issued as to MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc. on 1/12/2023. (Attachments: #1 Summons Issued, #2 Summons Issued)(twk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc. for KAI Pharmaceuticals, Inc. filed by Amgen Inc., KAI Pharmaceuticals, Inc. (twk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,162,500. (twk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 30, 2022. Date of Expiration of Patent: June 27, 2034. Thirty Month Stay Deadline: 8/7/2024. (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed against MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc. ( Filing fee $ 402, receipt number ADEDC-4042573.) - filed by Amgen Inc., KAI Pharmaceuticals, Inc. (Attachments: #1 Exhibit A, #2 Related Cases, #3 Civil Cover Sheet)(twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
